Targeting the Non-ATP-binding Pocket of the MAP Kinase P38γ Mediates a Novel Mechanism of Cytotoxicity in Cutaneous T-cell Lymphoma (CTCL)
Overview
Authors
Affiliations
We describe here for the first time a lipid-binding-domain (LBD) in p38γ mitogen-activated protein kinase (MAPK) involved in the response of T cells to a newly identified inhibitor, CSH71. We describe how CSH71, which binds to both the LBD and the ATP-binding pocket of p38γ, is selectively cytotoxic to CTCL Hut78 cells but spares normal healthy peripheral blood mononuclear (PBMC) cells, and propose possible molecular mechanisms for its action. p38γ is a key player in CTCL development, and we expect that the ability to regulate its expression by specifically targeting the lipid-binding domain will have important clinical relevance. Our findings characterize novel mechanisms of gene regulation in T lymphoma cells and validate the use of computational screening techniques to identify inhibitors for therapeutic development.
Pirfenidone ameliorates alcohol-induced promotion of breast cancer in mice.
Li H, Xu M, Chen D, Wen W, Luo J Front Oncol. 2024; 14:1351839.
PMID: 38590657 PMC: 10999600. DOI: 10.3389/fonc.2024.1351839.
Architecture of the MKK6-p38α complex defines the basis of MAPK specificity and activation.
Juyoux P, Galdadas I, Gobbo D, von Velsen J, Pelosse M, Tully M Science. 2023; 381(6663):1217-1225.
PMID: 37708276 PMC: 7615176. DOI: 10.1126/science.add7859.
p38γ MAPK Inflammatory and Metabolic Signaling in Physiology and Disease.
Qi X, Chen G Cells. 2023; 12(13).
PMID: 37443708 PMC: 10341180. DOI: 10.3390/cells12131674.
Hassan A, Oh Y, Lee C, Kim Y, Cho S, Alam M J Enzyme Inhib Med Chem. 2023; 38(1):2217695.
PMID: 37246947 PMC: 10228308. DOI: 10.1080/14756366.2023.2217695.